Business
Australian shares lose momentum, after Wall Street jumps on coronavirus vaccine developments – ABC News
Australian shares slip, despite Wall Street rising sharply on the back of COVID-19 vaccine developments and several multi-billion-dollar deals, while Qantas considers moving its Sydney headquarters to cut costs.
Australian shares have been flat for most of the day, even after Wall Street jumpedon the back of COVID-19 vaccine developments and several multi-billion-dollar deals.
Key points:
- The S&P 500 has surged 54pc since late March
- The ASX 200 has jumped 34pc in the past six months
- Central banks in the US, UK and Japan will decide on interest rates this week
By 2:15pm AEST, the benchmark ASX 200 index had slipped (-0.2pc) to 5,980 points.
Resource stocks were a…
Continue Reading
-
Business21 hours agoMacquarie tips 14% upside for this ASX tech stock
-
Noosa News17 hours agoWilliam Robinson dies aged 89
-
Business19 hours agoTop brokers name 3 ASX shares to buy today 27 August 2025
-
Business21 hours agoThis ASX 200 media stock is storming 7% higher to 52-week highs. Here’s why.